• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Organon

Biotech

Agios replaces CEO after recent FDA nod—Chutes & Ladders

Agios swaps out CEO after recent FDA nod. Altos Labs plucks Vir's CSO, bolstering leadership team. Two top Emerald execs resign amid SEC fraud probe.
Max Bayer , Gabrielle Masson Jul 15, 2022 9:30am

Organon buys Forendo in 3rd deal since spinning out of Merck

Nov 11, 2021 8:40am

Merck spinout Organon bags preterm labor drug ahead of phase 3

Jul 27, 2021 8:17am

Organon launches ready to shop for women's health companies

Jun 4, 2021 9:20am

Merck sets up $240M Alydia deal for its Organon spinout

Mar 30, 2021 8:53am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
  • ©2022 Questex LLC All rights reserved.
  • Terms of use
  • Privacy Policy